Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/1/12 → 9/15/14 |
Funding
- Radikal Therapeutics Inc (Agmt Signed 9/5/14 // Agmt Signed 9/5/14)
- National Institute of Neurological Disorders and Stroke (Agmt Signed 9/5/14 // Agmt Signed 9/5/14)
Tr1-Specific Tolerance: A Novel Treatment of Multiple Sclerosis
- Miller, Stephen D (PD/PI)
Project: Research project